2[1]Jeuleims RJ,Harper RW,Nesfek PJ,et al.Severity of coronary atherosclerotic heart disease related to lipoprotein concertration[J].BMJ,1978,12:6432-6441
3[2]Grundy SM,Cleeman JI,CN,et al.Impications of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guidelines[J].Circulation,2004,110:227-239
4[3]Cleeman JI.Executive summary of the third report of the national cholesterol education program (NCEP)expert panel on detection,evaluation,and treatment of high blood cholesterol in adults(adults treatment panel Ⅲ)[J].JAMA,2001,285:2486-2497
5[4]Bowman TS,Sesso HD,Ma J,et al.Cholesterol and the risk of ischemic stroke[J].Stoke,2003,34:2930-2934
6[6]Coughlan BJ,Sorrentio MJ.Dose hypertentriglyceridemia increase the risk of CAD[J].Post Gradual Med,2001,108:77-84
7Thompson D, Pepys MB, - Wood SP (1999) The physiologicalstructure of human C--reactive protein and its complex with phos- phocholine. (Translated from eng) Structure 7(2) : 169-- 177 (in eng).
8Ridker PM (2003) Clinical application of C--reactive protein for cardiovascular disease detection and prevention. (Translated from eng) Circulation 107(3):363--369 (in eng).
9Kuller LH (2006) Prevention of coronary heart disease and the Na- tional Cholesterol Education Program. (Translated from eng) Cir- culation 113(5):598--600 (in eng).
